Leqembi (lecanemab-irmb) - Biogen, Eisai
Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status. (PubMed, Cureus) - Sep 14, 2026 - "Sex- and race/ethnicity-related differences were exploratory and require validation in larger, more diverse prospective cohorts. These findings support genotype-informed ARIA surveillance while emphasizing the need for broader representation in studies of anti-amyloid therapy safety." 
Journal • Alzheimer's Disease • Cardiovascular • CNS Disorders • Diabetes • Dyslipidemia • Hypertension • Metabolic Disorders • APOE
http://www.ncbi.nlm.nih.gov/pubmed/42732414
 
Christina M Younan; Javier Romero; Jeremy N Ford; Matthew Wleklinski; Rafael E Martinez Imbett; Saurabh Rohatgi; Shenghua Zhu
 
Sep 14, 2026
 
Prev Next